期刊
JOURNAL OF INFECTIOUS DISEASES
卷 225, 期 3, 页码 364-366出版社
OXFORD UNIV PRESS INC
DOI: 10.1093/infdis/jiab382
关键词
dolutegravir; HIVDR; surveillance
资金
- President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention
To ensure the continued effectiveness of dolutegravir-based regimens, monitoring emerging drug resistance is crucial in order to inform treatment strategies for patients who are not responding to the treatment.
Dolutegravir-based regimens are now standard of care for human immunodeficiency virus treatment for millions of people around sub-Saharan Africa. To ensure its continued efficacy, monitoring of emerging drug resistance that inform a treatment strategy among those failing is crucial. In this report, we outline the US President's Emergency Plan for AIDS Relief to leverage viral load infrastructure to implement effective drug resistance surveillance in the countries it supports.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据